🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
SynCore Biotechnology Co.,Ltd (TPEX:4192)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.75
-0.35 (-2.17%)
Nov 20, 2026, 1:33 PM CST

TPEX:4192 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
25.8227.0423.3420.215.866.94
Revenue Growth
-1.68%15.88%15.55%27.36%128.52%-47.97%
Cost of Revenue
8.095.9610.4519.686.773.97
Gross Profit
17.7221.0912.890.529.092.97
Selling, General & Admin
45.6843.7742.3342.0943.3338.62
Research & Development
22.4824.5128.313.94157.23422.97
Operating Expenses
68.2368.2870.6446.02200.56461.59
Operating Income
-50.5-47.2-57.76-45.5-191.47-458.62
Interest Expense
-0.25-0.17-0.3-0.78-2.27-2.04
Interest & Investment Income
1.581.922.312.371.421.03
Currency Exchange Gain (Loss)
-0.44-0.441.165.65-2.99-4.17
Other Non Operating Income (Expenses)
0.570.020.010.096.775.2
EBT Excluding Unusual Items
-49.05-45.87-54.58-38.18-188.54-458.6
Gain (Loss) on Sale of Investments
0.120.120.3---
Gain (Loss) on Sale of Assets
-----0.13-
Other Unusual Items
---0.01--
Pretax Income
-48.94-45.76-54.28-38.17-188.67-458.6
Net Income
-48.94-45.76-54.28-38.17-188.67-458.6
Net Income to Common
-48.94-45.76-54.28-38.17-188.67-458.6
Net Income Growth
------
Shares Outstanding (Basic)
353535323130
Shares Outstanding (Diluted)
353535323130
Shares Change
0.04%-9.69%4.27%1.26%9.16%
EPS (Basic)
-1.39-1.30-1.54-1.19-6.14-15.10
EPS (Diluted)
-1.39-1.30-1.54-1.19-6.14-15.10
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-30.81-38.57-49.45-82.79-209.75-230.15
Free Cash Flow Per Share
-0.88-1.10-1.41-2.58-6.82-7.58
Gross Margin
68.65%77.98%55.22%2.58%57.30%42.79%
Operating Margin
-195.63%-174.52%-247.49%-225.30%-1207.50%-6609.30%
Profit Margin
-189.56%-169.19%-232.60%-189.01%-1189.80%-6608.98%
Free Cash Flow Margin
-119.34%-142.61%-211.89%-409.92%-1322.74%-3316.73%
EBITDA
-42.72-39.37-49.5-36.99-165.71-454.51
EBITDA Margin
-165.48%-145.60%-212.10%-183.16%--
D&A For EBITDA
7.787.828.268.5125.774.11
EBIT
-50.5-47.2-57.76-45.5-191.47-458.62
EBIT Margin
-195.63%-174.52%-247.49%-225.30%--